Mode
Text Size
Log in / Sign up
Phase 4 N=211 Randomized Double-blind Treatment

Study Comparing the Efficacy of Two Ibuprofen Formulations

Pain

Enrolled (actual)
211
Serious AEs
0.0%
Results posted
Aug 2010
Primary outcome: Primary: Time to Meaningful Pain Relief — 45.4; 63.6 minutes — p=<0.001

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
placebo (Drug); ibuprofen Formulation 1 (Drug); ibuprofen Formulation 2 (Drug)
Age
Pediatric, Adult · 16+ yrs
Sex
All
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Primary completion
Nov 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Meaningful Pain Relief
45.4; 63.6 <0.001 sig
SECONDARY
Pain Intensity Difference (PID) Scores at Each Individual Time Points
0.1; 0.2; 0.1; 0.2; 0.8; 0.5 0.118
SECONDARY
Pain Relief (PR) Scores at Individual Time Points
0.2; 0.5; 0.3; 0.6; 1.6; 1.0 0.041 sig
SECONDARY
Time-weighted Sum of Pain Relief + Pain Intensity Difference (SPRID) From 0-2 Hours and 0-6 Hours
1.8; 7.8; 6.3; 6.5; 24.0; 23.0 <0.001 sig
SECONDARY
Pain Relief Combined With Pain Intensity Difference (PRID) Scores at Individual Time Points
0.3; 0.7; 0.4; 0.8; 2.4; 1.4 0.056
SECONDARY
Time-weighted Sum of Pain Intensity Difference (SPID) From 0-2 Hours and 0-6 Hours
0.4; 2.8; 2.2; 1.4; 8.6; 8.1 <0.001 sig
SECONDARY
Time-weighted Sum of Pain Relief Scores (TOTPAR) From 0-2 Hours and 0-6 Hours
1.4; 5.0; 4.1; 5.1; 15.4; 14.9 <0.001 sig
SECONDARY
Time to First Perceptible Relief
23.7; 28.6 <0.001 sig

Summary

This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.

Eligibility Criteria

Inclusion criteria

  • Outpatients with post-operative pain following surgical extraction of third molars,
  • examined by the attending dentist or physician and medically cleared to participate in the study,
  • in general good health and have no contraindications to the study or rescue medication.

Exclusions criteria

  • any serious medical condition,
  • acute localized dental infection at the time of surgery ,
  • females who are pregnant, lactating, of child-bearing potential, or post-menopausal for less than 2 years and not using a medically approved method of contraception.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00740857). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search